Global and India Liquid Biopsy For Cancer Diagnostics Market Report & Forecast 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global and India Liquid Biopsy For Cancer Diagnostics Market Report & Forecast 2024-2034
Liquid biopsy for cancer diagnostics refers to a non-invasive medical test that analyzes blood or other body fluids to detect and analyze genetic alterations, proteins, or other molecules associated with cancer. Unlike traditional biopsies, which involve the surgical removal of a tissue sample, liquid biopsies provide a less invasive and more accessible method for detecting and monitoring cancer.
The global Liquid Biopsy For Cancer Diagnostics revenue was US$ 3603.7 million in 2022 and is forecast to a readjusted size of US$ 7887.5 million by 2033 with a CAGR of 12.4% during the review period (2023-2033).
In India, the Liquid Biopsy For Cancer Diagnostics revenue is expected to grow from US$ million in 2022 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
Researchers and developers continue to explore and expand the clinical utility of liquid biopsy. This includes investigating its application in various cancer types, different stages of cancer, and for monitoring treatment response and minimal residual disease.
This report focuses on global and India Liquid Biopsy For Cancer Diagnostics market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Liquid Biopsy For Cancer Diagnostics will continue to grow rapidly in the future.
Global Liquid Biopsy For Cancer Diagnostics Scope and Market Size
Liquid Biopsy For Cancer Diagnostics market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Liquid Biopsy For Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For India market, this report focuses on the Liquid Biopsy For Cancer Diagnostics market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in India.
F. Hoffman La Roche Ltd.
Thermo Fisher Scientific Inc.
Agilent Technologies Inc.
Illumina Inc.
The Menarini Group
Bio-Rad Laboratories Inc.
QIAGEN Inc.
Exact Sciences Corporation
Bio-Techne Corporation
ArcherDX Inc.
Neogenomics Laboratories Inc.
Guardant Health Inc.
Myriad Genetics Inc.
Foundation Medicine Inc.
Amoy Diagnostics Co. Ltd.
Biocartis Group NV
Segment by Type
Blood Test
Urine Test
Saliva Test
Hospital
Diagnostic Center
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter 1Introduces Liquid Biopsy For Cancer Diagnostics definition, global market size, India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Liquid Biopsy For Cancer Diagnostics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Liquid Biopsy For Cancer Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liquid Biopsy For Cancer Diagnostics revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
The global Liquid Biopsy For Cancer Diagnostics revenue was US$ 3603.7 million in 2022 and is forecast to a readjusted size of US$ 7887.5 million by 2033 with a CAGR of 12.4% during the review period (2023-2033).
In India, the Liquid Biopsy For Cancer Diagnostics revenue is expected to grow from US$ million in 2022 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
Researchers and developers continue to explore and expand the clinical utility of liquid biopsy. This includes investigating its application in various cancer types, different stages of cancer, and for monitoring treatment response and minimal residual disease.
This report focuses on global and India Liquid Biopsy For Cancer Diagnostics market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Liquid Biopsy For Cancer Diagnostics will continue to grow rapidly in the future.
Global Liquid Biopsy For Cancer Diagnostics Scope and Market Size
Liquid Biopsy For Cancer Diagnostics market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Liquid Biopsy For Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For India market, this report focuses on the Liquid Biopsy For Cancer Diagnostics market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in India.
By Company
F. Hoffman La Roche Ltd.
Thermo Fisher Scientific Inc.
Agilent Technologies Inc.
Illumina Inc.
The Menarini Group
Bio-Rad Laboratories Inc.
QIAGEN Inc.
Exact Sciences Corporation
Bio-Techne Corporation
ArcherDX Inc.
Neogenomics Laboratories Inc.
Guardant Health Inc.
Myriad Genetics Inc.
Foundation Medicine Inc.
Amoy Diagnostics Co. Ltd.
Biocartis Group NV
Segment by Type
Blood Test
Urine Test
Saliva Test
Segment by Application
Hospital
Diagnostic Center
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter Introduction
Chapter 1Introduces Liquid Biopsy For Cancer Diagnostics definition, global market size, India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Liquid Biopsy For Cancer Diagnostics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Liquid Biopsy For Cancer Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liquid Biopsy For Cancer Diagnostics revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices